Fate Therapeutics Inc. sell StockNews.com
Start price
10.03.23
/
50%
€4.55
Target price
10.03.24
-
Performance (%)
60.53%
End price
11.03.24
€7.31
Summary
This prediction ended on 11.03.24 with a price of €7.31. The price for Fate Therapeutics Inc. massively increased, which is bad news for the SELL prediction by StockNews_com. StockNews_com has a follow-up prediction for Fate Therapeutics Inc. where he still thinks Fate Therapeutics Inc. is a Sell. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Fate Therapeutics Inc. | -17.926% | -17.926% | 81.350% | -47.016% |
| iShares Core DAX® | 1,72 % | 3,37 % | 5,89 % | 52,38 % |
| iShares Nasdaq 100 | -4,56 % | -4,24 % | 21,39 % | 72,45 % |
| iShares Nikkei 225® | -7,12 % | -11,87 % | 42,36 % | 57,58 % |
| iShares S&P 500 | -0,89 % | 1,69 % | 19,49 % | 62,15 % |
Comments by StockNews_com for this prediction
In the thread Fate Therapeutics Inc. diskutieren
Fate Therapeutics, Inc. (NASDAQ: FATE) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for FATE provided by MarketBeat
In the thread Trading Fate Therapeutics Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Current prediction by StockNews_com for Fate Therapeutics Inc.
Stopped prediction by StockNews_com for Fate Therapeutics Inc.
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.88
28.06.25
28.06.25
-
28.06.26
28.06.26
118.77%
29.06.26
29.06.26
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€4.15
11.05.24
11.05.24
-
11.05.25
11.05.25
-76.44%
12.05.25
12.05.25